BAUWI MEDICAL
0834.235.434 · rovalta.com · 26/09/2026
BAUWI MEDICAL
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOBAUWI MEDICAL is a Private limited company incorporated in 2011. Its registered office is in Ixelles.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0834.235.434
- Incorporation
- 03/03/2011
- Legal form
- Private limited company
- Registered office
- Avenue Ernestine 12
1050 Ixelles · BruxellesSee on map - Contributed capital
- 1 000,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 16 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 306,6 k € | +9.7% | 279,5 k € | +27.7% | 218,9 k € | +24.6% | 175,7 k € | +16.4% | 151 k € |
| EBITDA | 305,3 k € | +9.5% | 278,9 k € | +28.5% | 217,1 k € | +24.5% | 174,4 k € | +15.9% | 150,4 k € |
| Operating result | 294,4 k € | +8.5% | 271,3 k € | +27.8% | 212,3 k € | +24.9% | 170 k € | +15.8% | 146,8 k € |
| Net result | 205,8 k € | +5.3% | 195,6 k € | +32.5% | 147,6 k € | +24.0% | 119 k € | +13.7% | 104,7 k € |
| Balance sheet | |||||||||
| Equity | 599,1 k € | +6.6% | 561,8 k € | +13.2% | 496,1 k € | +27.7% | 388,5 k € | +33.3% | 291,3 k € |
| Total assets | 632,2 k € | +8.3% | 583,9 k € | +10.7% | 527,4 k € | +28.7% | 409,7 k € | +18.6% | 345,5 k € |
| Cash | 557,7 k € | +6.6% | 523 k € | +5.2% | 497,1 k € | +29.4% | 384,2 k € | +20.0% | 320 k € |
| Debts | 33 k € | +50.2% | 22 k € | -29.8% | 31,3 k € | +47.1% | 21,3 k € | -60.7% | 54,1 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
Avenue Ernestine 12 1050 Ixelles| Company | CBE no. |
|---|---|
Cydaro Medical● Active | 1038.631.458 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 25/08/2026 | 08/07/2025 | 05/07/2024 | 31/08/2023 | 10/10/2022 | 24/08/2021 |
| General meeting | 17/08/2026 | 30/06/2025 | 28/06/2024 | 24/08/2023 | 29/08/2022 | 02/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 16 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 17/08/2026 | 25/08/2026 | French | |
| Micro model | 31/12/2024 | 30/06/2025 | 08/07/2025 | French | |
| Micro model | 31/12/2023 | 28/06/2024 | 05/07/2024 | French | |
| Micro model | 31/12/2022 | 24/08/2023 | 31/08/2023 | French | |
| Micro model | 31/12/2021 | 29/08/2022 | 10/10/2022 | French | |
| Micro model | 31/12/2020 | 02/04/2021 | 24/08/2021 | French | |
| Micro model | 31/12/2019 | 30/06/2020 | 23/07/2020 | French | |
| Micro model | 31/12/2018 | 05/04/2019 | 29/04/2019 | French | |
| Micro model | 31/12/2017 | 07/04/2018 | 21/08/2018 | French | |
| Micro model | 31/12/2016 | 07/04/2017 | 28/08/2017 | French | |
| Abridged modelCorrection | 31/12/2015 | 01/04/2016 | 27/09/2016 | French | |
| Abridged model | 31/12/2015 | 01/04/2016 | 18/08/2016 | French | |
| Abridged model | 31/12/2014 | 03/04/2015 | 11/06/2015 | French | |
| Abridged model | 31/12/2013 | 04/04/2014 | 26/08/2014 | French | |
| Abridged model | 31/12/2012 | 05/04/2013 | 30/08/2013 | French | |
| Abridged model | 31/12/2011 | 06/04/2012 | 03/08/2012 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025205,8 k €↑
- 2024Annual accounts 2024195,6 k €↑
- 2023Annual accounts 2023147,6 k €↑
- 2022Annual accounts 2022119 k €↑
- 2021Annual accounts 2021104,7 k €↓
- 2020Annual accounts 2020104,8 k €↑
- 2019Annual accounts 2019-64,7 k €↓
- 2018Annual accounts 201860,4 k €↓
- 2017Annual accounts 201766,4 k €↑
- 2016Annual accounts 201654,1 k €↓
- 2015Annual accounts 201558,6 k €↑
- 2014Annual accounts 201455,5 k €↑
- 2013Annual accounts 201330,8 k €↑
- 2012Annual accounts 201228,4 k €↓
- 2011Annual accounts 201129,8 k €
- 03/03/2011IncorporationPrivate limited company